GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Holy Stone Healthcare Co Ltd (ROCO:4194) » Definitions » Revenue

Holy Stone Healthcare Co (ROCO:4194) Revenue : NT$118.8 Mil (TTM As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Holy Stone Healthcare Co Revenue?

Holy Stone Healthcare Co's revenue for the six months ended in Dec. 2024 was NT$47.5 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was NT$118.8 Mil. Holy Stone Healthcare Co's Revenue per Share for the six months ended in Dec. 2024 was NT$0.33. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.84.

Warning Sign:

Holy Stone Healthcare Co Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Holy Stone Healthcare Co was -51.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was -24.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -14.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was -5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, Holy Stone Healthcare Co's highest 3-Year average Revenue per Share Growth Rate was 4.00% per year. The lowest was -24.90% per year. And the median was -2.50% per year.


Holy Stone Healthcare Co Revenue Historical Data

The historical data trend for Holy Stone Healthcare Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holy Stone Healthcare Co Revenue Chart

Holy Stone Healthcare Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 221.60 217.08 270.24 236.89 118.77

Holy Stone Healthcare Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.69 85.86 151.03 71.26 47.51

Competitive Comparison of Holy Stone Healthcare Co's Revenue

For the Biotechnology subindustry, Holy Stone Healthcare Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Holy Stone Healthcare Co's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Holy Stone Healthcare Co's Revenue distribution charts can be found below:

* The bar in red indicates where Holy Stone Healthcare Co's Revenue falls into.


;
;

Holy Stone Healthcare Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$118.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holy Stone Healthcare Co  (ROCO:4194) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Holy Stone Healthcare Co Revenue Related Terms

Thank you for viewing the detailed overview of Holy Stone Healthcare Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Holy Stone Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.

Holy Stone Healthcare Co Headlines

No Headlines